Clinical trial
Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With…
NCT00326209 · Bausch Health Americas, Inc., Industry · Completed
Key facts
| NCT number | NCT00326209 |
|---|---|
| Title | Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission |
| Official title | A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation |
| Lead sponsor | Bausch Health Americas, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ulcerative Colitis |
| Intervention type | Drug |
| Interventions | Encapsulated Mesalamine Granules (eMG) |
| Enrollment | 393 |
| Start date | Dec 22, 2005 |
| Primary completion | May 5, 2008 |
| Completion | May 5, 2008 |
| First posted | May 16, 2006 |
| Last update posted | Nov 1, 2019 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: